IPF is a life-threatening lung disease with no known cause. Over time, the lungs become scarred, making it harder to breathe. More than 250,000 Americans are living with IPF and other interstitial ...

Discover how weather conditions affect idiopathic pulmonary fibrosis (IPF) symptoms and learn practical tips to manage your ...

Achieving equitable access to anti-fibrotic drugs requires multi-stakeholder collaboration, while the most critical unmet ...

Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

New research identifies a specific monocyte gene signature that predicts mortality in IPF, offering potential targets ...

International Personal Finance said the U.K. takeover panel agreed to extend the deadline for BasePoint Capital to announce a firm intention to make an offer. IPF and U.S. peer BasePoint have been in ...

Idiopathic pulmonary fibrosis (IPF) is a rare and chronic lung condition. The word “idiopathic” means there’s no known cause of the condition, which can make diagnosing it difficult. A hacking cough ...

Investing.com -- PureTech Health PLC (NASDAQ:PRTC) stock fell 8.1% in premarket trading Monday after the company announced feedback from its End-of-Phase 2 meeting with the FDA regarding ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Prior to this trial, CS014 had positive outcomes in an ...

Long-held dogma says lung fibrosis in diseases like idiopathic pulmonary fibrosis, or IPF, results from recurrent injury to alveolar epithelium that is followed by dysregulated repair. Research at the ...

Please provide your email address to receive an email when new articles are posted on . Saracatinib appeared to be “equal or superior” in stopping fibrotic responses compared with two FDA-approved ...